Home
Conditions
Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Clinical trial condition

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Explore clinical trials studying Leukemia, Myelogenous, Chronic, BCR-ABL Positive. Study availability and eligibility vary by location and protocol.

601 public trials 70 recruiting studies

Refine in advanced search Browse all conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive trial results

Completed

Ipilimumab After Allogeneic Stem Cell Transplant in Treating Patients With Persistent or Progressive Cancer

NCT00060372

Conditions: Adnexal Diseases, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), +148 more
Locations: Scripps Clinic - La Jolla La Jolla, California, United States

University of California San Diego La Jolla, California, United States

Blood and Marrow Transplant Group of Georgia Atlanta, Georgia, United States

Northside Hospital Atlanta, Georgia, United States

View Trial Details

Completed

Methotrexate or Pentostatin for Graft-versus-host Disease Prophylaxis in Risk-adapted Allogeneic Bone Marrow Transplantation for Hematologic Malignancies

NCT01188798

Conditions: Acute Lymphoblastic Leukemia, Acute Myelocytic Leukemia, Bone Marrow Diseases, +26 more
Locations: St . Jude Children's Research Hospital Memphis, Tennessee, United States

View Trial Details

Completed

STI571 in Treating Patients With Chronic Myelogenous Leukemia in Blast Crisis

NCT00006475

Conditions: Blast Crisis, Bone Marrow Diseases, Carcinogenesis, +14 more
Locations: Novartis Pharmaceuticals Corporation East Hanover, New Jersey, United States

View Trial Details

Completed

Decitabine and FR901228 in Treating Patients With Relapsed or Refractory Leukemia, Myelodysplastic Syndromes, or Myeloproliferative Disorders

NCT00114257

Conditions: Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +46 more
Locations: M.D. Anderson Cancer Center at University of Texas Houston, Texas, United States

View Trial Details

Completed

Imatinib Mesylate in Treating Patients With Advanced Cancer and Liver Dysfunction

NCT00025415

Conditions: AIDS-related Peripheral/Systemic Lymphoma, AIDS-related Primary CNS Lymphoma, Accelerated Phase Chronic Myelogenous Leukemia, +170 more
Locations: University of Pittsburgh Pittsburgh, Pennsylvania, United States

View Trial Details

Completed

Dasatinib in Treating Young Patients With Recurrent or Refractory Solid Tumors or Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia or Chronic Myelogenous Leukemia That Did Not Respond to Imatinib Mesylate

NCT00316953

Conditions: Accelerated Phase Chronic Myelogenous Leukemia, Blast Crisis, Blastic Phase Chronic Myelogenous Leukemia, +29 more
Locations: Children's Oncology Group Arcadia, California, United States

View Trial Details

Completed

STI571 Plus Cytarabine in Treating Patients With Chronic Myelogenous Leukemia

NCT00015834

Conditions: Blast Crisis, Blastic Phase Chronic Myelogenous Leukemia, Bone Marrow Diseases, +17 more
Locations: University of California at Los Angeles (UCLA ) Los Angeles, California, United States

View Trial Details

Completed

Imatinib Mesylate and Decitabine in Treating Patients With Chronic Myelogenous Leukemia

NCT00054431

Conditions: Accelerated Phase Chronic Myelogenous Leukemia, Blast Crisis, Blastic Phase Chronic Myelogenous Leukemia, +20 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Homoharringtonine in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia

NCT00006364

Conditions: Bone Marrow Diseases, Childhood Chronic Myelogenous Leukemia, Chronic Disease, +15 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

STI571 in Treating Patients With Chronic Myelogenous Leukemia That Has Not Responded to Interferon Alfa

NCT00006053

Conditions: Bone Marrow Diseases, Chronic Disease, Disease Attributes, +11 more
Locations: Novartis Pharmaceuticals Corporation East Hanover, New Jersey, United States

View Trial Details

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Leukemia, Myelogenous, Chronic, BCR-ABL Positive trial results

Related conditions